Full Press Release Details
veopoz pozelimab bbfg receives fda approval as the first treatment for children and adults with chaple disease.
REGN
veopoz pozelimab bbfg receives fda approval as the first treatment for children and adults with chaple disease
Key Takeaway: veopoz pozelimab bbfg receives fda approval as the first treatment for children and adults with chaple disease